CytoNiche

Beijing Huakan Biotechnology Co., Ltd., led by Professor Yanan Du's research team from Tsinghua University School of Medicine and co-built with Tsinghua University’s participation, has its core technology rooted in the transformation of scientific achievements from Tsinghua University. Its original 3D FloTrix® series of products and supporting processes provide an overall solution for the scaled production of cell-based drugs, while also serving as an innovative injectable pharmaceutical excipient product capable of loading stem cells.CytoNiche has developed two pharmaceutical excipient products for the production of cell drug formulations: gelatin microcarriers and gelatin microcarrier films for cell use. These products have passed quality and safety evaluations by the National Institutes for Food and Drug Control (NIFDC) and obtained two qualifications as pharmaceutical excipients from the National Medical Products Administration (CDE registration numbers: F20210000003, F20210000496). Additionally, the product has received FDA DMF pharmaceutical excipient qualification in the United States (DMF: 35481).